Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (11189)	11/15/1997 7:22:00 PM
From: Andrew H	Read Replies (2) \| Respond to of 32384

I can understand the reaction a little better on the AMLN thread since there the bad news would immediately affect the stock price, as in fact it soon did. As for the AGPH response, it is more difficult to understand. The stock is doing well and viracept sales will continue to skyrocket. While emerging resistance of the virus to protease inhibitors and the cocktail is clearly a setback, it was expected by many who were familiar with the exceptional ability of the virus to mutate. I guess there are a few people who simply cannot accept anything which does not fit into their game plan. And others who are jealous of those who understand the science, but to lazy too do the work to understand it themselves. And of course as Bev said, there are those malcontents with perennial personality problems, looking to disrupt threads where people have formed congenial relationships.